SEAN CHAPPIN: Open Payments
NPI 1679740427 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,937 in 222 payments from 15 companies in 2025. Trend: 2023 $3,061 · 2024 $4,047 · 2025 $4,937
Food & beverage: $4,937
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 42 | $922 |
| ABBVIE INC. | 31 | $857 |
| Janssen Pharmaceuticals, Inc | 25 | $710 |
| Alkermes, Inc. | 14 | $376 |
| Teva Pharmaceuticals USA, Inc. | 19 | $368 |
| Otsuka America Pharmaceutical, Inc. | 13 | $277 |
| Axsome Therapeutics, Inc. | 12 | $250 |
| E.R. Squibb & Sons, L.L.C. | 13 | $237 |
| Neurocrine BioSciences, Inc. | 12 | $219 |
| Lundbeck LLC | 10 | $193 |
Products named: CAPLYTA, VRAYLAR, SPRAVATO, REXULTI, ARISTADA, Auvelity, COBENFY, INGREZZA.
Industry payments across NY — which companies pay providers there.
